关注
farhad Assarzadegan
farhad Assarzadegan
在 sbmu.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group
S Shahjouei, G Tsivgoulis, G Farahmand, E Koza, A Mowla, A Vafaei Sadr, ...
Stroke 52 (5), e117-e130, 2021
862021
Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache
A Shahrami, F Assarzadegan, HR Hatamabadi, M Asgarzadeh, ...
The Journal of emergency medicine 48 (1), 69-76, 2015
692015
Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case–control study and review of the literature
F Assarzadegan, S Asgarzadeh, HR Hatamabadi, A Shahrami, ...
International Clinical Psychopharmacology 31 (5), 287-292, 2016
482016
Central nervous system manifestations in COVID‐19 patients: a systematic review and meta‐analysis
S Nazari, A Azari Jafari, S Mirmoeeni, S Sadeghian, ME Heidari, ...
Brain and Behavior 11 (5), e02025, 2021
452021
Risk factors for increased multiple sclerosis susceptibility in the Iranian population
B Mansouri, S Asadollahi, K Heidari, M Fakhri, F Assarzadegan, M Nazari, ...
Journal of Clinical Neuroscience 21 (12), 2207-2211, 2014
452014
The efficacy of gabapentin in patients with central post-stroke pain
O Hesami, N Beladimoghadam, F Assarzadegan, B Mansouri, ...
Iranian Journal of Pharmaceutical Research: IJPR 14 (Suppl), 95, 2015
432015
Secondary headaches attributed to arterial hypertension
F Assarzadegan, M Asadollahi, O Hesami, O Aryani, B Mansouri
Iranian Journal of Neurology 12 (3), 106, 2013
362013
Neurological features and outcome in COVID-19: dementia can predict severe disease
M Ghaffari, H Ansari, N Beladimoghadam, SH Aghamiri, M Haghighi, ...
Journal of NeuroVirology 27, 86-93, 2021
332021
Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial
M Asadollahi, P Nikdokht, B Hatef, SS Sadr, H Sahraei, F Assarzadegan, ...
Journal of ethnopharmacology 238, 111833, 2019
332019
Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study
O Hesami, HD Kasmaei, F Matini, F Assarzadegan, B Mansouri, ...
Journal of clinical and diagnostic research: JCDR 9 (4), OC08, 2015
322015
Relation of stroke risk factors with specific stroke subtypes and territories
F Assarzadegan, H Tabesh, A Shoghli, MG Yazdi, H Tabesh, ...
Iranian Journal of Public Health 44 (10), 1387, 2015
262015
Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions
M Mehrpour, A Shuaib, M Farahani, HR Hatamabadi, Z Fatehi, M Ghaffari, ...
International Journal of Stroke 16 (9), 1047-1052, 2021
242021
Mortality and functional disability after spontaneous intracranial hemorrhage: the predictive impact of overall admission factors
B Mansouri, K Heidari, S Asadollahi, M Nazari, F Assarzadegan, A Amini
Neurological Sciences 34, 1933-1939, 2013
242013
COVID-19 respiratory illness and subsequent cerebrovascular events, the initial iranian experience
B Sabayan, M Moghadami, F Assarzadegan, SHA Komachali, ...
Journal of Stroke and Cerebrovascular Diseases 30 (1), 105454, 2021
202021
Comparison of pregabalin and sodium valproate in migraine prophylaxis: a randomized double-blinded study
O Hesami, MR Shams, L Ayazkhoo, F Assarzadegan, BS Lima, ...
Iranian journal of pharmaceutical research: IJPR 17 (2), 783, 2018
202018
Acute management of stroke in Iran: Obstacles and solutions
S Shahjouei, R Bavarsad-Shahripour, F Assarzadegan, R Rikhtegar, ...
Iranian journal of neurology 16 (2), 62, 2017
172017
Tolerability and efficacy of memantine as add on therapy in patients with migraine
F Assarzadegan, M Sistanizad
Iranian journal of pharmaceutical research: IJPR 16 (2), 791, 2017
172017
Evaluation of ocular side effects in the patients on topiramate therapy for control of migrainous headache
O Hesami, SS Hosseini, N Kazemi, SM Hosseini-Zijoud, NB Moghaddam, ...
Journal of clinical and diagnostic research: JCDR 10 (3), NC01, 2016
172016
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran
H Pakdaman, A Amini Harandi, K Gharagozli, M Abbasi, A Tabassi, ...
International Journal of Neuroscience 127 (6), 501-507, 2017
162017
Efficacy and safety of MLC601 in the treatment of mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled study
H Pakdaman, A Amini Harandi, M Abbasi, H Delavar Kasmaei, F Ashrafi, ...
Dementia and Geriatric Cognitive Disorders Extra 7 (1), 136-142, 2017
122017
系统目前无法执行此操作,请稍后再试。
文章 1–20